Literature DB >> 16453288

Overexpression of caveolin-1 results in increased plasma membrane targeting of glycolytic enzymes: the structural basis for a membrane associated metabolic compartment.

Leena S Raikar1, Johana Vallejo, Pamela G Lloyd, Christopher D Hardin.   

Abstract

Although membrane-associated glycolysis has been observed in a variety of cell types, the mechanism of localization of glycolytic enzymes to the plasma membrane is not known. We hypothesized that caveolin-1 (CAV-1) serves as a scaffolding protein for glycolytic enzymes and may play a role in the organization of cell metabolism. To test this hypothesis, we over-expressed CAV-1 in cultured A7r5 (rat aorta vascular smooth muscle; VSM) cells. Confocal immunofluorescence microscopy was used to study the distribution of phosphofructokinase (PFK) and CAV-1 in the transfected cells. Areas of interest (AOI) were analyzed in a central Z-plane across the cell transversing the perinuclear region. To quantify any shift in PFK localization resulting from CAV-1 over-expression, we calculated a periphery to center (PC) index by taking the average of the two outer AOIs from each membrane region and dividing by the central one or two AOIs. We found the PC index to be 1.92 +/- 0.57 (mean +/- SEM, N = 8) for transfected cells and 0.59 +/- 0.05 (mean +/- SEM, N = 11) for control cells. Colocalization analysis demonstrated that the percentage of PFK associated with CAV-1 increased in transfected cells compared to control cells. The localization of aldolase (ALD) was also shifted towards the plasma membrane (and colocalized with PFK) in CAV-1 over-expressing cells. These results demonstrate that CAV-1 creates binding sites for PFK and ALD that may be of higher affinity than those binding sites localized in the cytoplasm. We conclude that CAV-1 functions as a scaffolding protein for PFK, ALD and perhaps other glycolytic enzymes, either through direct interaction or accessory proteins, thus contributing to compartmented metabolism in vascular smooth muscle. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16453288     DOI: 10.1002/jcb.20732

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  17 in total

Review 1.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

2.  Identification of the components of a glycolytic enzyme metabolon on the human red blood cell membrane.

Authors:  Estela Puchulu-Campanella; Haiyan Chu; David J Anstee; Jacob A Galan; W Andy Tao; Philip S Low
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

3.  Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins.

Authors:  Yoshitaka Kawaraguchi; Yousuke T Horikawa; Anne N Murphy; Fiona Murray; Atsushi Miyanohara; Sameh S Ali; Brian P Head; Piyush M Patel; David M Roth; Hemal H Patel
Journal:  Anesthesiology       Date:  2011-09       Impact factor: 7.892

Review 4.  Caveolins in vascular smooth muscle: form organizing function.

Authors:  Christopher D Hardin; Johana Vallejo
Journal:  Cardiovasc Res       Date:  2006-01-04       Impact factor: 10.787

5.  Mechanism of aldolase control of sorting nexin 9 function in endocytosis.

Authors:  Erumbi S Rangarajan; HaJeung Park; Emanuelle Fortin; Jurgen Sygusch; Tina Izard
Journal:  J Biol Chem       Date:  2010-02-02       Impact factor: 5.157

6.  AKAP79 Orchestrates a Cyclic AMP Signalosome Adjacent to Orai1 Ca2+ Channels.

Authors:  Pulak Kar; Pradeep Barak; Anna Zerio; Yu-Ping Lin; Amy J Parekh; Val J Watts; Dermot M F Cooper; Manuela Zaccolo; Holger Kramer; Anant B Parekh
Journal:  Function (Oxf)       Date:  2021-07-29

7.  Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning.

Authors:  Yasuo M Tsutsumi; Yousuke T Horikawa; Michelle M Jennings; Michael W Kidd; Ingrid R Niesman; Utako Yokoyama; Brian P Head; Yasuko Hagiwara; Yoshihiro Ishikawa; Atsushi Miyanohara; Piyush M Patel; Paul A Insel; Hemal H Patel; David M Roth
Journal:  Circulation       Date:  2008-10-20       Impact factor: 29.690

8.  Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury.

Authors:  Yousuke T Horikawa; Hemal H Patel; Yasuo M Tsutsumi; Michelle M Jennings; Michael W Kidd; Yasuko Hagiwara; Yoshihiro Ishikawa; Paul A Insel; David M Roth
Journal:  J Mol Cell Cardiol       Date:  2007-10-11       Impact factor: 5.000

Review 9.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

10.  Role of caveolae in cardiac protection.

Authors:  David M Roth; Hemal H Patel
Journal:  Pediatr Cardiol       Date:  2011-01-06       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.